Orchestra BioMed Holdings Inc.
OBIO
$5.45-5.05%
End of day · as of Oct 16, 2026, 8:00 PM ET
Mkt cap
$231.74M
EV/Sales
6.33
P/E ratio
N/A
FY2025 Revenue
$33.48M
EPS (TTM)
$-0.84
Gross Margin (FY2025)
99.43%
Profit Margin (FY2025)
-157.40%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported OBIO revenue for 2025-12-31 was $33.5M. Net income was -$52.7M. Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. OBIO currently screens at market cap $231.7M.
Use this OBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full OBIO income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company in the Healthcare sector.
Latest cached Orchestra BioMed Holdings Inc. (OBIO) revenue for Dec 31, 2025 was $33.5M. Net income was -$52.7M. Statements: https://lician.com/financials/obio
Orchestra BioMed Holdings Inc. (OBIO) market capitalization is $231.7M on the latest cached snapshot.
Orchestra BioMed Holdings Inc. (OBIO) cached previous close $5.74; day range $5.43 – $5.75; volume 422,516. Session quote: https://lician.com/quote/obio
Orchestra BioMed Holdings Inc. (OBIO) latest cached earnings event is "OBIO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached OBIO filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/obio